1. Home
  2. CSBR vs GECC Comparison

CSBR vs GECC Comparison

Compare CSBR & GECC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Champions Oncology Inc.

CSBR

Champions Oncology Inc.

N/A

Current Price

$6.25

Market Cap

83.5M

Sector

Health Care

ML Signal

N/A

GECC

Great Elm Capital Corp.

HOLD

Current Price

$6.16

Market Cap

79.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSBR
GECC
Founded
1985
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
83.5M
79.9M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
CSBR
GECC
Price
$6.25
$6.16
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$10.75
AVG Volume (30 Days)
5.7K
64.3K
Earning Date
03-12-2026
05-12-2026
Dividend Yield
N/A
22.06%
EPS Growth
161.11
N/A
EPS
N/A
N/A
Revenue
$2,900,000.00
N/A
Revenue This Year
$4.84
$0.92
Revenue Next Year
$11.51
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.50
$4.63
52 Week High
$9.63
$11.45

Technical Indicators

Market Signals
Indicator
CSBR
GECC
Relative Strength Index (RSI) 57.68 67.50
Support Level $6.14 $4.74
Resistance Level $6.29 $7.07
Average True Range (ATR) 0.25 0.22
MACD 0.03 0.06
Stochastic Oscillator 79.71 85.00

Price Performance

Historical Comparison
CSBR
GECC

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

About GECC Great Elm Capital Corp.

Great Elm Capital Corp is an externally managed, non-diversified closed-end management investment company. It generates both income and capital appreciation through debt and income-generating equity investments, including investments in finance businesses. The Company operates as a single reportable segment with an investment objective to generate both current income and capital appreciation through debt and equity investments and manages the business on a consolidated basis.

Share on Social Networks: